You are here

  • Home
  • Archive
  • Volume 76, Issue 7
  • Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Coghlan JG, Galiè N, Barberà JA for the AMBITION investigators, et al
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
Annals of the Rheumatic Diseases 2017;76:1219-1227.